NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Agency: Food and Drug Administration
Assistance Listings: 93.103 -- Food and Drug Administration Research
Description
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening, and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreement is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Email: jenise.mcnair@fda.hhs.gov
Documents
No documents are currently available.
Link to additional information
Closing: April 1, 2027
Award
$5,000,000
Program Funding
35
Expected awards
$--
Award Minimum
$200,000
Award Maximum
Funding opportunity number:
PAR-25-014
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Agriculture
Consumer protection
Food and nutrition
Category Explanation:
History
Version:
1
Posted date:
July 11, 2025
Archive date:
May 1, 2027
